
DBV Technologies
DBV | PA
Overview
Corporate Details
- ISIN(s):
- FR0010417345 (+3 more)
- LEI:
- 969500PVBQFWQKVDMD80
- Country:
- France
- Address:
- 107 AVENUE DE LA REPUBLIQUE, 92320 CHATILLON
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
DBV Technologies is a clinical-stage biopharmaceutical company focused on developing treatments for food allergies. The company's core innovation is the VIASKIN® patch, a proprietary platform for epicutaneous immunotherapy (EPIT). This investigational technology is designed to re-educate the immune system by delivering minimal amounts of antigens to intact skin, offering a potential non-invasive therapeutic approach. DBV's development pipeline is led by its VIASKIN® Peanut patch (DBV712), which has advanced to Phase 3 clinical studies. The company is also researching applications for other food allergies, including milk. Founded by pediatricians, DBV aims to improve the lives of patients with potentially life-threatening allergies.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for DBV Technologies.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-20 12:46 |
Major Shareholding Notification
Franchissement de seuils
|
French | 124.2 KB | |
2025-06-17 16:58 |
Major Shareholding Notification
Franchissement de seuils
|
French | 107.2 KB | |
2025-06-12 22:05 |
Earnings Release
DBV Technologies to Participate in Upcoming EAACI Congress 2025
|
English | 275.8 KB | |
2025-06-12 22:05 |
Regulatory News Service
DBV Technologies participera au prochain congrès EAACI 2025
|
French | 269.7 KB | |
2025-06-11 22:30 |
Post-Annual General Meeting Information
DBV Technologies annonce les résultats de son Assemblée Générale Mixte 2025
|
French | 179.9 KB | |
2025-06-11 22:30 |
Declaration of Voting Results & Voting Rights Announcements
DBV Technologies Announces the Voting Results of its 2025 Combined General Meet…
|
English | 179.7 KB | |
2025-06-04 22:32 |
Declaration of Voting Results & Voting Rights Announcements
Information Regarding the Total Number of Voting Rights and Total Number of Sha…
|
English | 169.6 KB | |
2025-06-04 22:32 |
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total des droits de vote et d’actions composant…
|
French | 150.3 KB | |
2025-06-03 22:30 |
Registration Form
DBV Technologies publie un amendement à son Document d’enregistrement universel…
|
French | 178.9 KB | |
2025-06-03 22:30 |
Registration Form
DBV Technologies announces the filing of an addendum to the 2024 Universal Regi…
|
English | 171.4 KB | |
2025-05-15 22:30 |
Pre-Annual General Meeting Information
Assemblée Générale Mixte du 11 juin 2025
|
French | 173.8 KB | |
2025-05-15 22:30 |
Pre-Annual General Meeting Information
Combined General Meeting of June 11, 2025
|
English | 193.4 KB | |
2025-05-06 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Information regarding the total number of voting rights and total number of s…
|
English | 95.0 KB | |
2025-05-06 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total des droits de vote et d’actions composant…
|
French | 100.7 KB | |
2025-05-05 22:30 |
Regulatory News Service
DBV Technologies participera à la conférence Citizens JMP Life Sciences
|
French | 174.6 KB |
Automate Your Workflow. Get a real-time feed of all DBV Technologies filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for DBV Technologies via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2022-06-09 | N/A | Other | Other | 2,483,161 | 7,449,483.00 EUR |